{"status": "Ok", "redirect_url": "https://www.merck.com/media/news/?title=FDA+Approves+KEYTRUDA%C2%AE+(pembrolizumab)+and+KEYTRUDA+QLEX%E2%84%A2+(pembrolizumab+and+berahyaluronidase+alfa-pmph),+each+with+Trodelvy%C2%AE+(sacituzumab+govitecan-hziy)+as+First-Line+Treatment+of+PD-L1++(CPS+%E2%89%A510)+Advanced+Triple-Negative+Breast+Cancer+(TNBC)", "message": "News view counter 816159 successfully enlarged"}